FENNEC PHARMACEUTICALS INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q1 2024.
  • Fennec Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $39M.
  • Fennec Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$17.1M, a 5.07% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$18.1M, a 27% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$14.2M, a 8.8% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $39M +$44.6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 -$5.58M -$2.72M -95.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q2 2022 -$12.4M -$3.39M +$1.04M +23.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$13.5M -$2.86M +$737K +20.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$14.2M -$3.25M +$39K +1.19% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$14.3M -$2.96M +$2.49M +45.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$16.7M -$4.43M -$1.31M -42% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$15.4M -$3.59M +$156K +4.16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$15.6M -$3.28M -$1.69M -107% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$13.9M -$5.45M -$3.21M -144% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10.7M -$3.12M -$360K -13.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$10.3M -$3.75M -$1.27M -51.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$9.06M -$1.59M +$1.34M +45.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$10.4M -$2.24M -$636K -39.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$9.76M -$2.76M -$1.19M -75.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$8.58M -$2.48M -$752K -43.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$7.83M -$2.93M -$1.61M -122% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 -$6.22M -$1.6M -$641K -66.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$5.58M -$1.57M -$882K -128% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$4.69M -$1.73M -$1.05M -156% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$3.64M -$1.32M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$958K -$414K -76.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$688K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$675K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$544K -$35K -6.88% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q3 2015 -$1.91M -$509K -$66K -14.9% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$1.84M -$511K -$101K -24.6% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-11
Q1 2015 -$1.74M -$418K -$40K -10.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q4 2014 -$1.7M -$468K -$23K -5.17% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-31
Q3 2014 -$1.68M -$443K +$26K +5.54% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.7M -$410K +$479K +53.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$2.18M -$378K +$29K +7.13% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$2.21M -$445K +$112K +20.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$2.32M -$469K +$257K +35.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$2.58M -$889K +$244K +21.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$2.82M -$407K +$171K +29.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.99M -$557K +$2.76M +83.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$5.75M -$726K -$90K -14.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$5.66M -$1.13M -$2.91M -164% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$2.76M -$578K +$470K +44.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$3.23M -$3.31M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$636K -$86K -15.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $1.77M +$2.16M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.05M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$550K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$386K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.